ArticleCureus2026
Giant Benign Ovarian Serous Cystadenoma in a Postmenopausal Woman.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant benign serous cystadenomas are ovarian tumors predominantly found in postmenopausal women, often presenting with nonspecific symptoms prior to diagnosis. This case study discusses an 80-year-old postmenopausal woman who experienced dyspnea and lower abdominal pain, leading to a contrast-enhanced abdominal computed tomography that revealed a well-defined giant cystic mass. The patient underwent a total hysterectomy with bilateral salpingo-oophorectomy (THBSO), with the excised specimen measuring 40 cm in diameter and weighing approximately 7.7 kg. Histopathological examination confirmed that cyst formation was lined by a single layer of columnar and cuboidal epithelium with fibrous stroma, identifying it as a benign serous cystadenoma. The patient had an uneventful postoperative recovery over 60 days. The uniqueness of this case lies in the patient's age and the atypical clinical presentation of the giant cystic mass. Additional clinical multicenter studies and molecular studies are needed to be done in the future in order to better understand the mechanism creating these tumors and tumorigenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.